438 Studies Now Enrolling
REDUCE LAP-HF RANDOMIZED TRIAL I: A study to evaluate the Corvia Medical, Inc. IASD System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure
REDUCE LAP-HF RANDOMIZED TRIAL II: Study of IASD System II to Reduce Left Atrial Pressure in Patients with Heart Failure
| Sponsor: | Corvia Medical, Inc. |
| Enrolling: | Male and Female Patients |
| IRB Number: | AAAS4609 |
| U.S. Govt. ID: | NCT03088033 |
| Contact: | Kate Dalton: (347) 514-3366 / keb2114@cumc.columbia.edu |
Additional Study Information:
The primary objective of this randomized controlled clinical trial is to evaluate the clinical efficacy and safety of the IASD System II in symptomatic heart failure patients with an LV ejection fraction 40%, and elevated left sided filling pressures despite standard Guideline Directed Medical Therapy (GDMT).
This study is closed
